Pulmonx Corp (LUNG) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$32.38M | -2.7% |
| 2024 | -$31.54M | +16.1% |
| 2023 | -$37.61M | +16.6% |
| 2022 | -$45.08M | -8.9% |
| 2021 | -$41.39M | -35.1% |
| 2020 | -$30.63M | -47.5% |
| 2019 | -$20.77M | -12.9% |
| 2018 | -$18.39M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$32.38M | -2.7% |
| 2024 | -$31.54M | +16.1% |
| 2023 | -$37.61M | +16.6% |
| 2022 | -$45.08M | -8.9% |
| 2021 | -$41.39M | -35.1% |
| 2020 | -$30.63M | -47.5% |
| 2019 | -$20.77M | -12.9% |
| 2018 | -$18.39M | — |